Intravitreal Ranibizumab for Choroidal Neovascularization Secondary to Pathological Myopia: 12-Month Follow-Up

Publisher： Karger

E-ISSN： 1423-0267|226|3|103-109

ISSN： 0030-3755

Source： Ophthalmologica, Vol.226, Iss.3, 2011-06, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: Five-year Follow-up

By Zebardast Nazlee   Adelman Ron A.  

Seminars in Ophthalmology, Vol. 27, Iss. 3-4, 2012-07 ,pp. : 61-64

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma

By  

Case Reports in Ophthalmology, Vol. 3, Iss. 2, 2012-06 ,pp. : 200-204

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab

By  

Case Reports in Ophthalmology, Vol. 8, Iss. 1, 2017-04 ,pp. : 221-231

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab

By  

Ophthalmologica, Vol. 227, Iss. 1, 2011-11 ,pp. : 39-44

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12-month Follow-Up and Prognostic Factors

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 207-215

Karger

Access to resources Recommend Favorite